Royal Bank of Canada
TTRX

Royal Bank of Canada’s Turn Therapeutics TTRX Stock Holding History

Royal Bank of Canada’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+28,250
New +$131K ﹤0.01% 4971
2026
Q1 		– Sell
-267
Closed -$1K – 7938
2025
Q4 		$1K Buy
+267
New +$1.11K ﹤0.01% 7105

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return

Royal Bank of Canada's TTRX Position: Q2 2026 in Review

Royal Bank of Canada opened a new position in Turn Therapeutics (TTRX) in Q2 2026: 28,250 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #4971 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in TTRX as recently as Q4 2025.

Royal Bank of Canada first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Royal Bank of Canada held 28,250 shares of Turn Therapeutics worth $206K as of Q2 2026.
  • Turn Therapeutics was a new Royal Bank of Canada position in Q2 2026.
  • Turn Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4971 holding.
  • Royal Bank of Canada first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.